|
A phase 2/3 trial to investigate the safety and immunogenicity of monovalent Omicron JN.1-adapted BNT162b2 COVID-19 vaccine in adults ≥18 years old |
|
|
|
Titel: |
A phase 2/3 trial to investigate the safety and immunogenicity of monovalent Omicron JN.1-adapted BNT162b2 COVID-19 vaccine in adults ≥18 years old |
Auteur: |
Diya, Oyeniyi Gayed, Juleen Lowry, Francine S. Ma, Hua Bangad, Vishva Mensa, Federico Zou, Jing Xie, Xuping Hu, Yanping Cutler, Mark Belanger, Todd Cooper, David Xu, Xia Koury, Kenneth Türeci, Özlem Şahin, Uǧur Swanson, Kena A. Modjarrad, Kayvon Anderson, Annaliesa S. Gurtman, Alejandra Kitchin, Nicholas |
Verschenen in: |
Vaccine |
Paginering: |
Jaargang 52 () nr. C pagina's p. |
Jaar: |
2025 |
Inhoud: |
|
Uitgever: |
Published by Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|